Paul Greengard of Rockefeller University shared the 2000 Nobel Prize in Medicine or Physiology for his work on signal transduction in the brain. He and Per Svenningsson, of the Rockefeller and the Karolinska Institute in Stockholm, write on page 40 about the discovery of DARPP-32 and its subsequent characterization as a master regulator in the brain, integrating signals involved in drugs of abuse as well as schizophrenia and depression. "One of the major challenges was to prove that these pathways were physiologically relevant," Greengard says. "We know much more now that I would have guessed possible 25 years ago."












